A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 4, 2008, Pages 788-794

  Wickens, Kristin ^a   Black, Peter N ^c   Stanley, Thorsten V ^a   Mitchell, Edwin ^c   Fitzharris, Penny ^d   Tannock, Gerald W ^b   Purdie, Gordon ^a   Crane, Julian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

allergic disease; allergy prevention; atopy; eczema; infants; Probiotics; randomized controlled trial

Indexed keywords

ALLERGEN; PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPY; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BREAST FEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECZEMA; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; PREGNANT WOMAN; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

BIFIDOBACTERIUM; BREAST FEEDING; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS RHAMNOSUS; MALE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROBIOTICS;

EID: 53049095486     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.011     Document Type: Article

References (31)

1. Strachan D. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 55 suppl 1 (2000) S2-S10
2. Sepp E., Julge K., Vasar M., Naaber P., Bjorksten B., and Mikelsaar M. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 86 (1997) 956-961
3. Vaarala G. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy 33 (2003) 1634-1640
4. Blumer N., Sel S., Virna S., Patrascan C., Zimmermann S., Herz U., et al. Perinatal maternal application of Lactobacillus rhamnosus GG suppresses allergic airway inflammation in mouse offspring. Clin Exp Allergy 37 (2007) 348-357
5. Kalliomaki M., Salminen S., Arvilommi H., Kero P., Koskinen P., and Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
6. Kalliomaki M., Salminen S., Poussa T., Arvillommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4 year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
7. Kalliomaki M., Salminen S., Poussa T., and Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119 (2007) 1019-1021
8. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Probiotics and prebiotics galacto-oligosaccharides in the prevention of allergic disease: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 119 (2007) 192-198
9. Abrahamsson T., Jakobsson T., Bottcher M., Fredrikson M., Jenmalm M., and Oldaeus N.B.G. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 119 (2007) 1174-1180
10. Taylor A., Dunstan J., and Prescott S. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119 (2007) 184-191
11. Kopp M., Hennemuth I., Heinzmann A., and Urrbanek R. Randomized, double-blind, placebo-controlled trial for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121 (2008) e1-e7
12. Williams H.C., Burney P.G.J., Hay R.J., Archer C.B., Shipley M.J., Hunter J.J.A., et al. The UK Working Party's Diagnostic Criteria for Atopic Dermatitis. Br J Dermatol 131 (1994) 383-396
13. Williams H. So how do I define atopic eczema? a practical manual for researchers wishing to define atopic eczema. 1996. Available at: http://www.nottingham.ac.uk/dermatology/eczema/contents/html Accessed August 8, 2008.
14. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 186 (1993) 23-31
15. ASCIA Skin Prick Testing Working Party. Skin prick testing for the diagnosis of allergic disease: a manual for practitioners. 2006. Available at: http://www.allergy.org.au/images/stories/pospapers/ASCIA_SPT_Manual_Sep_06.pdf Accessed August 8, 2008.
16. Epton M., Town I., Ingham T., Wickens K., Fishwick D., Crane J., et al. The New Zealand Asthma and Allergy Cohort Study (NZA2CS): assembly, demographics and investigations. BMC Public Health 7 (2007) 26
17. Tannock G., Munro K., Harmsen H., Welling G., Smart J., and Gopal P. Analysis of the fecal microflora of human subjects consuming a probiotic containing Lactobacillus rhamnosus DR20. Appl Environ Microbiol 66 (2000) 2578-2588
18. Requena T., Burton J., Matsuki T., Munro K., Simon M., Tanaka R., et al. Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol 68 (2002) 2420-2427
19. Walter J., Hertel C., Tannock G., Lis C., Munro K., and Hammes W. Detection of Lactobacillus, Pediococcus, Leuconostic and WeisellaII species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67 (2001) 2578-2585
20. Ahrne S., Nobeck S., Jeppson B., Adlerberth I., Wold A., and Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 85 (1998) 88-94
21. Janer C., Arigoni F., Lee B., Pelaez C., and Requena T. Enzymatic ability of Bifidobacterium animalis subsp. lactis to hydrolyze milk proteins: identification and characterization to endopeptidase O. Appl Environ Microbiol 71 (2005) 8460-8465
22. Kim S.-Y., and Adachi Y. Biological and genetic classification of canine intestinal lactic acid bacteria and bifidobacteria. Microbiol Immunol 51 (2007) 919-928
23. Mah K., Chin V., Wong W., Lay C., Tannock G., Shek L., et al. Effect of milk formula containing probiotics on the fecal microbiota of Asian infants at risk of atopic diseases. Pediatr Res 62 (2007) 674-679
24. Osborn D., and Sinn J. Probiotics in infants for prevention of allergic disease and food hypersensitivity. [review]. Cochr Database Syst Rev (2007) CD006474
25. Lee J., Seto D., and Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 121 (2008) 116-121
26. Perez P., Dore J., Leclerc M., Levenez F., Benyacoub J., Serrant P., et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells?. Pediatrics 119 (2007) E724-E732
27. Prescott S., and Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol 120 (2007) 255-262
28. Niers L., Timmerman H., Rijkers G., van Bleek G., van Uden N., Knol E., et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35 (2005) 1481-1489
29. Prescott S.L., Wicken K., Westcott L., Nieblee J., Currie H., Black P., et al. Supplementation with Loctobacillus, rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood IFN-γ and breast milk TGF-β and IgA detection. Clin Exp Allergy (2008) In press
30. Statistics New Zealand. 2006 NZ census of population and dwellings: QuickStats About Culture and Identity 2006 Census 2006. Available at: http://www.stats.govt.nz/census/2006-census-data/quickstats-about-culture-identity/quickstats-about-culture-and-identity.htm Accessed February 28, 2008.
31. Ministry of Health. Tobacco trends 2006: monitoring tobacco use in New Zealand (2006), Ministry of Health, Wellington